Dr. Rajiv Perera

Dr. Rajiv Perera, a proud alumnus of Royal College, Colombo, is a seasoned pharmaceutical and medical marketing expert with over two decades of global industry leadership. He has held senior positions at renowned multinational pharmaceutical companies including Novartis-Sandoz GMBH, Sanofi Aventis, CSL Behring, Octapharma AG, Cytosorbents Inc., Reliance Life Sciences, and LG Chem, gaining extensive expertise across biologicals, biosimilars, and critical care portfolios.

Currently, Dr. Perera serves as the Chief Executive Officer of LAUGFS Life Sciences, where he leads strategic initiatives to strengthen Sri Lanka’s pharmaceutical manufacturing sector through innovation and sustainable industry practices. He previously served as Board Director – Marketing at ABC Pharma, one of Sri Lanka’s leading importers of biological and biosimilar pharmaceuticals, where he spearheaded transformational marketing and regulatory strategies.

Dr. Perera holds a Doctor of Business Administration (DBA) from Vern University, Croatia, and a Master of Science in Marketing with Distinction from Cardiff Metropolitan University, UK. He is also a Member of the Chartered Institute of Marketing (MCIM), UK, and an Indexed Author in Oxford Academic (UK) as well as an Indexed Professional in Bloomberg (USA)—recognitions that highlight his contributions to both academic and corporate research domains.

As an ardent academic, Dr. Perera serves as a Visiting Lecturer and Master’s Thesis Supervisor at several international universities, including the University of Gloucestershire (UK), Vern University (Croatia), and Brittany University (France). He has also lectured for Cardiff Metropolitan University (ICBT, Sri Lanka). His scholarly interests include Marketing Strategy, Emotional Intelligence, Neuro-Marketing, Psychology, and Consumer Behavior, with numerous publications in peer-reviewed indexed journals.

In addition, Dr. Perera is a certified ISO Auditor accredited by the Sri Lanka Standards Institution (SLSI). He has led multiple local and international audits and ISO certification projects in Quality Assurance (QA), Good Distribution Practice (GDP), and Pharmacovigilance, contributing significantly to improving compliance and operational efficiency in regulated environments.